| Chemotherapy for gynecologic cancers occurring during pregnancy. | |
| | |
MedLine Citation:
|
PMID: 21794193 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Chemotherapy treatment of gynecologic malignancies during pregnancy should provide maternal benefit without undue fetal harm. We review the treatment regimens for gynecologic cancers occurring during pregnancy and the effects of chemotherapy on fetal development, parturition, and lactation. Women diagnosed with a gynecologic cancer during pregnancy require individualized treatment plans from a multidisciplinary team. Target Audience: Obstetricians & Gynecologists, Family Physicians Learning Objectives: After completing this CME activity, physicians should be better able to specify the indications for chemotherapy in gynecologic cancers during pregnancy and postpartum periods, discuss the risks and benefits of chemotherapy for gynecologic cancer during pregnancy and postpartum periods. In addition, they should also be able to distinguish the mechanism of action of various chemotherapy agents to choose the best treatment options for patients and monitor for impacts of chemotherapy on fetal growth to determine the best treatment and management strategies. |
| | |
Authors:
|
Emily M Ko; Linda Van Le |
Related Documents
:
|
8729873 - Infection by the human papillomavirus in teenagers sexually active: clinic and subclini... 2808083 - Adolescent third-trimester enrollment in prenatal care. 15099863 - Is the monitoring of anti-xa activity necessary in pregnant women undergoing thrombopro... |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Obstetrical & gynecological survey Volume: 66 ISSN: 1533-9866 ISO Abbreviation: Obstet Gynecol Surv Publication Date: 2011 May |
Date Detail:
|
Created Date: 2011-07-28 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0401007 Medline TA: Obstet Gynecol Surv Country: United States |
Other Details:
|
Languages: eng Pagination: 291-8 Citation Subset: IM |
Affiliation:
|
*Gynecologic Oncology Fellow, †Professor, University of North Carolina, Division of Gynecologic Oncology, Chapel Hill, NC. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Bio-nanopatterning of Surfaces.
Next Document: Vulvodynia interventions-systematic review and evidence grading.